Version May 2024
| Bladder cancer history | 2-year local recurrence from baseline transurethral resection of bladder tumor (%) | Time interval to transplant |
| NMIBC low risk* | 19 | 6 months |
| Intermediate risk¶ | 39 | 6 months |
| High riskΔ | 38 | 2 years |
| MIBC, postradical cystectomy | 25 to 37 | 2 years |
| MIBC, postchemoradiation | 25 to 30 (10-year) | Not an SOT candidate |
NMIBC: nonmuscle invasive bladder cancer; MIBC: muscle invasive bladder cancer.
* Low risk: Solitary, ≤3 cm, low-grade, Ta tumor, absence of carcinoma in situ (CIS).
¶ Intermediate risk: Solitary tumor >3 cm, recurrence within 12 months with low-grade Ta tumor, multifocal low-grade Ta tumor, low-grade T1 tumor, or high-grade tumor <3 cm.
Δ High risk: Any CIS, high-grade Ta tumor >3 cm, high-grade T1 tumor, multifocal high-grade Ta tumor, any recurrent high-grade Ta tumor, CIS, variant histology, lymphovascular invasion, high-grade prostatic urethral involvement, recurrence after BCG intravesical therapy. Although 2-year recurrence rate is lower than intermediate risk, the progression rate to muscle invasion is higher.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
